William Dai is listed as a director on 3 SEC Form D filings by 1 issuer between Jan 2023 and Feb 2026: KoKo Medical, Inc. (Malvern, PA — other health care — 2023–2026; $8.7M reported sold to 37 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Jason Keiser (3 shared filings), Matthew Topliff (3 shared filings), Michael Wallace (3 shared filings), Skott Greenhalgh (3 shared filings), Megan Rosengarten (2 shared filings) and 1 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around William. Each name links to their own page.
The issuer belongs to the sponsor group Koko (3 issuers, $20.9M reported sold, 2020–2026).
What this means A sponsor group is one team that sets up a new company for each deal. Koko has 3 companies on file and $20.9M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 3 public filings for William Dai and found 6 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "William Dai" (CA) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.